In adults with T2D and either established ASCVD or multiple risk factors for ASCVD, we recommend use of: GLP-1RA or SGLT2i to reduce the risk of all-cause or CV mortality or MACE (Strong Recommendation
Expanding application scope to explore interventions in aging-related diseases (neurodegenerative diseases, cardiovascular diseases, metabolic diseases), providing new strategies for their prevention and treatment
"Certain areas of the body, like the abdomen or thigh (common injection sites), may be more prone to bruising due to blood vessel density or tissue sensitivity." Dr
No bowel movement for 7+ days
In this case, you will receive your order every 60-days like normal, but receive an additional vial of medication in your scheduled delivery
This provides actual purity data rather than relying on vendor-supplied certificates of analysis